Hind Medyouf
- Hematology top 5%
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 4
- Oncology top 10%
- CAR-T cell therapy research 3
-
- MicroRNA in disease regulation 2
- Immunology top 10%
- Genetics top 10%
-
- Signaling Pathways in Disease 3
- Histone Deacetylase Inhibitors Research 3
-
- Acute Lymphoblastic Leukemia research 3
-
- Bone and Dental Protein Studies 2
- Co-authors
- Jacques GhysdaelHenner F. FarinAndrew P. WengBirgitta E. MichelsSamuel GusscottFrançoise PflumioAnne JaninHugues de Thé
- Cited by
- HematologyOncologyCancer Research
In The Last Decade
Hind Medyouf
23 papers receiving 961 citations
Peers
Comparison fields: 5 of 79
- Hematology 247
- Oncology 298
- Cancer Research 157
- Immunology 220
- Genetics 108
Countries citing papers authored by Hind Medyouf
This map shows the geographic impact of Hind Medyouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind Medyouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind Medyouf more than expected).
Fields of papers citing papers by Hind Medyouf
This network shows the impact of papers produced by Hind Medyouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind Medyouf. The network helps show where Hind Medyouf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hind Medyouf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 57 | |
| 7 | 2020 | 170 | |
| 8 | 2017 | 90 | |
| 9 | 2016 | 12 | |
| 10 | 2016 | 21 | |
| 11 | 2014 | 58 | |
| 12 | 2014 | 26 | |
| 13 | 2011 | 4 | |
| 14 | 2011 | 131 | |
| 15 | 2010 | 3 | |
| 16 | 2009 | 7 | |
| 17 | 2009 | 65 | |
| 18 | 2008 | 90 | |
| 19 | 2007 | 124 | |
| 20 | 2006 | 30 |
About Hind Medyouf
Hind Medyouf is a scholar working on Hematology, Genetics and Cancer Research, having authored 23 papers that have together received 976 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers), Signaling Pathways in Disease (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Bone and Dental Protein Studies (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Hematology (247 citations), Oncology (298 citations) and Cancer Research (157 citations). Hind Medyouf has collaborated with scholars based in Germany, France and Canada. Frequent co-authors include Jacques Ghysdael, Henner F. Farin, Andrew P. Weng, Birgitta E. Michels, Samuel Gusscott, Françoise Pflumio, Anne Janin, Hugues de Thé, Didier Decaudin and Nuno R. dos Santos. Their work appears in journals such as Blood, Leukemia, The Journal of Experimental Medicine, The Journal of Cell Biology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.